On Monday, Immunic Inc (NASDAQ: IMUX) opened lower -5.22% from the last session, before settling in for the closing price of $1.15. Price fluctuations for IMUX have ranged from $0.92 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 54.58% at the time writing. With a float of $87.36 million, this company’s outstanding shares have now reached $90.08 million.
The extent of productivity of a business whose workforce counts for 77 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunic Inc is 3.02%, while institutional ownership is 57.18%. The most recent insider transaction that took place on Nov 12 ’24, was worth 100,369. In this transaction Director of this company bought 87,300 shares at a rate of $1.15, taking the stock ownership to the 87,300 shares.
Immunic Inc (IMUX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.90% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Check out the current performance indicators for Immunic Inc (IMUX). In the past quarter, the stock posted a quick ratio of 2.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.77 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
The latest stats from [Immunic Inc, IMUX] show that its last 5-days average volume of 0.61 million was inferior to 0.96 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 26.70%. Additionally, its Average True Range was 0.09.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 20.95%, which indicates a significant decrease from 23.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.63% in the past 14 days, which was higher than the 64.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0505, while its 200-day Moving Average is $1.2559. Now, the first resistance to watch is $1.1333. This is followed by the second major resistance level at $1.1765. The third major resistance level sits at $1.2032. If the price goes on to break the first support level at $1.0634, it is likely to go to the next support level at $1.0367. The third support level lies at $0.9935 if the price breaches the second support level.
Immunic Inc (NASDAQ: IMUX) Key Stats
There are currently 90,079K shares outstanding in the company with a market cap of 98.19 million. Presently, the company’s annual sales total 0 K according to its annual income of -93,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,370 K.
